Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1802-1810

  Lu, Su ^a   Yan, Dongwang ^a   Wu, Zehua ^a   Jiang, Tao ^a   Chen, Jian ^a   Yuan, Lin ^a   Lin, Jun ^a   Peng, Zhihai ^a   Tang, Huamei ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Colon cancer; Prognosis; Progression; Tissue microarray; Ubiquitin like with PHD and ring finger domains 2

Indexed keywords

MESSENGER RNA; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAINS 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG TARGETING; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL PREDICTION; TISSUE MICROARRAY; TUMOR INVASION; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAIN 2 GENE; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; YOUNG ADULT;

EID: 84908123681     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3035     Document Type: Article

References (26)

1. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
4. Zhang S, Cui Y, Weng Z, Gong X, Chen M and Zhong B: Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years. Int J Colorectal Dis 24: 943-949, 2009.
5. Petrova TV, Nykänen A, Norrmén C, et al: Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 13: 407-419, 2008.
6. Sansom OJ, Meniel VS, Muncan V, et al: Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679, 2007.
7. Micel LN, Tentler JJ, Smith PG and Eckhardt GS: Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol 31: 1231-1238, 2013.
8. Bedford L, Lowe J, Dick LR, Mayer RJ and Brownell JE: Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 10: 29-46, 2011.
9. Reinstein E and Ciechanover A: Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann Intern Med 145: 676-684, 2006.
10. Naujokat C and Sarić T: Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells. Stem Cells 25: 2408-2418, 2007.
11. Bronner C, Achour M, Arima Y, Chataigneau T, Saya H and Schini-Kerth VB: The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 115: 419-434, 2007.
12. Hopfner R, Mousli M, Jeltsch JM, et al: ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIα expression. Cancer Res 60: 121-128, 2000.
13. Mori T, Li Y, Hata H, Ono K and Kochi H: NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem Biophys Res Commun 296: 530-536, 2002.
14. Kotliarov Y, Steed ME, Christopher N, et al: High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66: 9428-9436, 2006.
15. Wu J, Liu S, Liu G, et al: Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene 31: 333-341, 2012.
16. Li DW, Tang HM, Fan JW, et al: Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 136: 997-1006, 2010.
17. Yan DW, Fan JW, Yu ZH, et al: Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta 1822: 918-926, 2012.
18. Troup S, Njue C, Kliewer EV, et al: Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9: 207-214, 2003.
19. Bachmann IM, Puntervoll HE, Otte AP and Akslen LA: Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol 21: 583-590, 2008.
20. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G and Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6: 241, 2006.
21. Lorenzato M, Caudroy S, Bronner C, et al: Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Patho 36: 1101-1107, 2005.
22. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al: Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129: 1454-1463, 2005.
23. Unoki M, Kelly JD, Neal DE, Ponder BA, Nakamura Y and Hamamoto R: UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer 101: 98-105, 2009.
24. Wu TF, Zhang W, Su ZP, et al: UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro. Asian Pac J Cancer Prev 13: 5137-5142, 2012.
25. Sun Y: E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8: 645-654, 2006.
26. Ma C, Rong Y, Radiloff DR, et al: Extracellular matrix protein βig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22: 308-321, 2008.